In Re: Purdue Pharma L.P.

District Court, S.D. New York·Decided November 26, 2024·No. 7:24-cv-07042·Unknown

Opinion

USDC sUNI \| DOCUMENT □ ELECTRGNIC/ “LY FILED UNITED STATES DISTRICT COURT | ELECTRONIC; SOUTHERN DISTRICT OF NEW YORK DOC #: Se Se Chapter 11 PURDUE PHARMA L.P., et al., Case No. 19-23649 (SHL) Debtors. ! (Jointly Administered) Adv. Pro. No. 19-08289 a eee ew STATE OF MARYLAND, Appellant, VS. Case No. 24-Civ-7042

PURDUE PHARMA L.P., et al., Appellees.” nr ee

MEMORANDUM DECISION AND ORDER AFFIRMING VARIOUS ORDERS OF THE BANKRUPTCY COURT THAT EXTENDED A PRELIMINARY INJUNCTION

: The Debtors in these cases, along with the last four digits of each Debtor’s registration number in the applicable jurisdiction, are as follows: Purdue Pharma L.P. (7484), Purdue Pharma Inc. (7486), Purdue Transdermal Technologies L.P. (1868), Purdue Pharma Manufacturing L.P. (3821), Purdue Pharmaceuticals L.P. (0034), Imbrium Therapeutics L.P. (8810), Adlon Therapeutics L.P. (6745), Greenfield BioVentures L.P. (6150), Seven Seas Hill Corp. (4591), Ophir Green Corp. (4594), Purdue Pharma of Puerto Rico (3925), Purdue Products L.P. (4140), Purdue Pharmaceutical Products L.P. (3902), Purdue Neuroscience Company (4712), Nayatt Cove Lifescience Inc. (7805), Button Land L.P. (7502), Rhodes Associates L.P. (N/A), Paul Land Inc. (7425), Quidnick and L.P, (7584), Rhodes Pharmaceuticals L.P. (6166), Rhodes Technologies (7143), UDF LP (0495), SVC Pharma LP (5717), and SVC Pharma Inc. (4014). The Debtors’ corporate headquarters is located at One Stamford Forum, 201 Tresser Boulevard, Stamford, CT 06901. 2 Appellees in this case are the Debtors and the Official Committee of Unsecured Creditors of Purdue Pharma L.P., et al.

McMahon, J.: This appeal is taken from three order that extended a preliminary injunction issued during the adversary proceeding Purdue Pharma, L.P., et al. v. Commonwealth of Massachusetts, et al., Adv. Pro. No. 19-08289 (the “Adversary Proceeding”), filed in the United States Bankruptcy Court for the Southern District of New York (“Bankruptcy Court”) (Lane, U.S.B.J.).3 Appellant, the State of Maryland, asks this Court to vacate the Bankruptcy Court’s grant of the Thirty-Seventh Amended Order Pursuant to 11 U.S.C. § 105(a) Granting Motion for a Preliminary Injunction, dated September 6, 2024, Adv. Dkt. No. 533 (“September 6, 2024 Extension Order”), the Thirty- Eighth Amended Order Pursuant to 11 U.S.C. § 105(a) Granting Motion for a Preliminary Injunction, dated September 27, 2024, Adv. Dkt. No. 557 (“September 27, 2024 Extension Order’’), and the Thirty-Ninth Amended Order Pursuant to 11 U.S.C. § 105(a) Granting Motion for a Preliminary Injunction dated November 1, 2024, Adv. Dkt. No. 583 (“November 1, 2024 Extension Order’). Since the oral argument of this appeal, the Debtors have moved for a further extension. Adv. Dkt. No. 590. The Court is advised that Maryland will be filing a notice of appeal if that extension is granted at a hearing being held before Judge Lane today. See Dkt. No. 59. Maryland asserts that same ground for overturning each of the extension orders. The Court assumes familiarity with the facts and extensive procedural history of the case. See Inre Purdue Pharm. L.P., 619 B.R. 38 (S.D.N.Y. 2020); In re Purdue Pharma, L.P., 635 B.R. 26 (S.D.N.Y. 2021), rev’d and remanded sub nom. In Re Purdue Pharma L.P., 69 F.4th 45 (2d Cir. 2023), rev'd and remanded sub nom. Harrington v. Purdue Pharma L. P., 144 S. Ct. 2071 (2024).

3 On July 1, 2022, the Adversary Proceeding was reassigned from Judge Robert D. Drain (Ret.) to Judge Sean H. Lane. Adv. Dkt. No. 360.

The preliminary injunction in question (the “Preliminary Injunction’’) was entered shortly after the Debtors identified in footnote | (collectively referred to as “Purdue”) filed petitions in bankruptcy. It enjoins all governmental and private plaintiffs from continuing or commencing any judicial, administrative, or other actions, against the Debtors—Purdue Pharma L.P., certain affiliated debtors, as debtors or debtors in possession—as well as certain non-debtors,* including former or current owners, directors, officers, and other entities associated with Purdue Pharma L.P. (each a “Related Party”; together, the “Related Parties”). See Second Amended Order Pursuant to 1] U.S.C. § 105(a) Granting Motion for a Preliminary Injunction, dated November 6, 2019, Adv. Dkt. No. 105 (“November 6, 2019 Order’). Of specific interest, the injunction extends to those members of the Sackler Family who at all relevant times owned and controlled Purdue, as well as entities (such as trusts) of which the Sackler Family members are owners or beneficiaries. This injunction is considerably broader than the automatic stay that is imposed on most (but not all) litigation against a bankrupt (and only against a bankrupt) pursuant to 11 U.S.C.

4 The Related Parties are: The Purdue Frederick Company Inc.; The P.F. Laboratories Inc.; Purdue Pharma Technologies Inc.; PLP Associates Holdings L.P.; PLP Associates Holdings Inc.; BR Holdings Associates L.P.; BR Holdings Associates Inc.; Rosebay Medical Company L.P.; Rosebay Medical Company, Inc.; Beacon Company; PRA Holdings Inc.; Pharmaceutical Research Associates Inc.; Purdue Holdings L.P.; Rhodes Pharmaceuticals Inc.; Rhodes Technologies Inc.; Coventry Technologies L.P.; MNP Consulting Limited; Richard S. Sackler; the Estate of Jonathan D. Sackler; Jonathan D. Sackler; Mortimer D.A. Sackler; Kathe A. Sackler; Ilene Sackler Lefcourt; the Estate of Beverly Sackler; Beverly Sackler; Theresa Sackler; David A. Sackler; Marianna Sackler; Estate of Mortimer Sackler; Estate of Raymond Sackler; Trust for the Benefit of Members of the Raymond Sackler Family; Raymond Sackler Trust; Beverly Sackler, Richard S$. Sackler, and Jonathan D. Sackler, as Trustees Under Trust Agreement Dated November 5, 1964; Beverly Sackler, Richard S. Sackler, and Jonathan D. Sackler, as Trustees Under Trust Agreement Dated November 5, 1974; Paulo Costa; Cecil Pickett; Ralph Snyderman; Judith Lewent; Craig Landau; Mark Timney; Stuart D. Baker; Frank Peter Boer; John Stewart; Russell Gasdia; Marv Kelly; Shelli Liston; Heather Weaver; Doug Powers; Lori Fuller; Rodney Davis; Brandon Worley; Donald Leathers; Wendy Kay; Michael Madden; LeAvis Sullivan; Jeffrey Ward; Beth Taylor; Leigh Varnadore; Paul Kitchin; Mark Waldrop; Mark Radcliffe; Mark Ross; Patty Carnes; Carol Debord; Jeff Waugh; Shane Cook; James David Haddox; Aida Maxsam; Tessa Rios; Amy K. Thompson; Joe Coggins; Lyndsie Fowler; Mitchell “Chip” Fisher; Rebecca Sterling; Vanessa Weatherspoon; Chris Hargrave; Brandon Hassenfuss; Joe Read; Andrew T. Stokes; Nathan C. Grace; Jaclyn P. Gatling; Leslie Roberson; Barbara C. Miller; Briann Parson- Barnes; Becca Beck Harville; Lindsey Bonifacio; Tammy Heyward; James Speed; Damon Storhoff; Diana C. Muller; and Draupadi Daley.

§ 362(b)(4). The Bankruptcy Court issued the Preliminary Injunction pursuant to 11 U.S.C. § 105(a) and Fed. R. Bankr. P. 7065, to enjoin what the automatic stay could not: (1) governmental actions to enforce regulatory or police powers, and (2) actions against the Related Parties that might have an impact on the res of the bankruptcy estate.

Free access — add to your briefcase to read the full text and ask questions with AI

In Re: Purdue Pharma L.P., (S.D.N.Y. 2024).

In Re: Purdue Pharma L.P. (In Re: Purdue Pharma L.P.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Devose v. Herrington
42 F.3d 470 (Eighth Circuit, 1994)
Zervos v. Verizon New York, Inc.
252 F.3d 163 (Second Circuit, 2001)
U. S. Bank N. A. v. Village at Lakeridge, LLC
583 U.S. 387 (Supreme Court, 2018)
SPV Osus Ltd. v. UBS AG
882 F.3d 333 (Second Circuit, 2018)
Picard v. Fairfield Greenwich Ltd.
762 F.3d 199 (Second Circuit, 2014)
Elliott v. General Motors LLC
829 F.3d 135 (Second Circuit, 2016)
Lautenberg Foundation v. Picard
512 F. App'x 18 (Second Circuit, 2013)
JTH Tax D/B/A Liberty Tax Service v. Agnant
62 F.4th 658 (Second Circuit, 2023)